Category: Finance
-
Baxter Acquires Sickle-Cell Prevention Drug Developer
10 July 2014. Baxter International in Deerfield, Illinois is acquiring AesRx LLC, a biopharmaceutical company in Newton, Massachusetts developing drugs for sickle-cell and other rare diseases. Baxter is making an initial payment to AesRx, which will be eligible for future payments tied to development and commercial milestones, but dollar amounts were not disclosed. Sickle cell…
-
Panel: Federal Science Cuts Hurt U.S. Competitiveness
9 July 2014. A panel of research executives from 10 universities in the U.S. told of the harmful impact of Federal spending cuts on science in the past few years, which the panelists said reduces the country’s ability to compete in world markets. The roundtable discussion at the National Press Club in Washington, D.C. was…
-
DARPA Funding Development of Brain Implants to Boost Memory
9 July 2014. Defense Advanced Research Projects Agency, a division of the U.S. Department of Defense, is awarding grants to two universities and a national lab to develop devices for implanting in the brain that can sense and restore memory loss. Research agreements totaling $40 million were designated for University of California in Los Angeles,…
-
NIH Funds $24 Million for Genetic Links to Alzheimer’s
8 July 2014. National Institutes of Health is awarding $24 million to eight academic medical centers for research on genomic factors behind people developing or avoiding Alzheimer’s disease. Recipients of the four-year grants are Boston University, Case Western Reserve University in Cleveland, Columbia University in New York, University of Miami, University of Pennsylvania, University of…
-
Univ at Buffalo Starting Advanced Materials Research Center
1 July 2014. University at Buffalo in New York is establishing a new materials research department that aims to accelerate the process of bringing advanced materials to market. Buffalo’s Materials Design and Innovation department is a joint project of the university’s engineering and Arts and Science schools, and funded in part by donation of $1.5…
-
Student Project Aims to Land Time Capsule on Mars
23 June 2014. Students from four U.S. universities — with help from research labs, not-for-profit organizations, and companies — are building a space vehicle to propel and land a time capsule of digital files from earth on the surface of Mars. The Time Capsule to Mars project also plans to raise $25 million through crowdfunding…
-
Challenge Seeks Development Partner for Nanotech Biosensor
20 June 2014. A new challenge on InnoCentive calls for a medical technology company or institute to develop a new type of nanoscale biosensor for diagnostic and therapeutic applications. The challenge has no immediate financial award, but winners of the competition will earn the right to negotiate a compensated collaboration contract with the Cleveland Clinic,…
-
U.K. Public-Private Partnership to Attack Dementia
20 June 2014. Medical Research Council, a science funding agency in the U.K., organized a consortium of academic and industry researchers to better detect, prevent, and treat dementia. The council and six industry partners plan to spend £16 million ($US 27.25 million) on the U.K. Dementias Research Platform that includes studies involving some 2 million…
-
Foundation, Biopharm Partner on RNA-Interference Therapy
19 June 2014. Alnylam Pharmaceuticals Inc. in Cambridge, Massachusetts and the Alpha-1 Project in Miami are collaborating on advancing Alnylam’s therapy to treat alpha-1 antitrypsin deficiency, a rare genetic condition responsible for liver disorders and a lung disease similar to chronic obstructive pulmonary disease or COPD. Alpha-1 Project is the for-profit venture division of the…
-
Portfolio Model Proposed for Funding Alzheimer’s Research
18 June 2014. Financial and biomedical researchers at Massachusetts Institute of Technology, University of California in Santa Barbara, and the biotechnology company Genentech outlined a different approach to funding research on Alzheimer’s disease that supports multiple simultaneous studies addressing various drug targets. The team led by MIT finance professor Andrew Lo published its findings today…